Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
Nature Genetics2002Vol. 30(4), pp. 377–384
Citations Over TimeTop 1% of 2002 papers
Related Papers
- → Valproic acid increases SMN levels in spinal muscular atrophy patient cells(2003)288 cited
- → Spinal Muscular Atrophy Diagnostics(2007)107 cited
- → SMN-Inducing Compounds For The Treatment Of Spinal Muscular Atrophy(2012)34 cited
- → Deletion Analysis of SMN1 Exon 7 Alone May Be Necessary and Sufficient for the Diagnosis of Spinal Muscular Atrophy(2011)3 cited
- → AB140. Ten years experiences of diagnosis spinal muscular atrophy using molecular techniques(2015)